Best Lung Cancer Treatment Hospital in Lucknow 

Fuda Cancer Hospital – Lung Cancer Care for Lucknow Patients

Lucknow patients searching for safe and advanced lung cancer treatment can take guidance from Fuda Cancer Hospital. Fuda’s main hospital is in Guangzhou, China. In India, Fuda works with its official partner Rekosh Health Care to provide online consultations, expert opinions and treatment guidance. There is no full Fuda hospital in Lucknow, but patients can easily access personalised treatment planning, online consultation and follow-up support. For in-person visits, Fuda has two Indian centres — Mumbai and Noida Consultation Centres, where patients receive follow-up treatment and palliative care.

Advanced Lung Cancer Care for Patients Across Lucknow & Uttar Pradesh

A diagnosis of lung cancer can be one of the most challenging moments in a person’s life. Patients and families often have many questions. What type of lung cancer is it? Has it spread? Is surgery the best option? Would immunotherapy or targeted therapy be more suitable? Should a second opinion be obtained before starting treatment?

For patients living in Lucknow, Kanpur, Prayagraj, Varanasi, Gorakhpur, Bareilly, Ayodhya, Jhansi, Agra, Meerut, Aligarh, Moradabad, and other parts of Uttar Pradesh, access to expert guidance and reliable medical information is essential for making informed treatment decisions.

Lung cancer remains one of the leading causes of cancer-related deaths worldwide. Although smoking continues to be the most important risk factor, an increasing number of patients are being diagnosed despite having no history of tobacco use. Air pollution, passive smoking, occupational exposure, biomass fuel smoke, previous lung diseases, and genetic factors also contribute to the development of lung cancer.

Lucknow has become one of the major medical centres in North India, attracting patients from across Uttar Pradesh and neighbouring states. Many families travel to the city for advanced diagnostic services, multidisciplinary cancer care, specialist consultations, and treatment planning.

One of the greatest challenges with lung cancer is that it often develops silently. During its early stages, symptoms may be absent or resemble common respiratory illnesses such as bronchitis, seasonal allergies, or recurrent chest infections. Persistent cough, breathlessness, chest pain, coughing up blood, unexplained weight loss, hoarseness of voice, and repeated respiratory infections should never be ignored.

Fortunately, remarkable advances in oncology have transformed lung cancer treatment. Modern imaging, molecular diagnostics, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary care now enable doctors to develop personalised treatment plans based on the cancer type, stage, molecular profile, and the patient’s overall health.

Fuda Cancer Hospital, with its internationally recognised cancer centre in Guangzhou, China, collaborates with Rekosh Health Care in India to support patients seeking expert consultation, second opinions, personalised treatment planning, and coordinated follow-up care. Patients from Lucknow can upload CT scans, PET-CT images, biopsy reports, pathology findings, molecular testing reports, and previous treatment records for expert review. When an in-person assessment is required, consultation centres in Noida and Mumbai provide additional support.

Depending on the diagnosis, treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, Cryotherapy, NanoKnife Irreversible Electroporation (IRE), or a carefully planned combination of these approaches. Every treatment recommendation is tailored according to the patient’s diagnosis, lung function, stage of disease, molecular profile, and treatment goals.

This comprehensive guide has been developed specifically for patients from Lucknow and across Uttar Pradesh. It explains lung cancer in simple language, discusses symptoms, diagnosis, staging, treatment options, recovery, nutrition, rehabilitation, and answers frequently asked questions to help patients and families make confident healthcare decisions.

Why Lung Cancer Is Becoming a Growing Health Concern in Lucknow

Lung cancer is becoming an increasingly important public health concern across Uttar Pradesh. While smoking remains the leading cause, environmental and occupational factors also play a significant role.

Rapid urbanisation, increasing traffic density, industrial emissions, seasonal air pollution, biomass fuel smoke, and passive smoking all contribute to respiratory illnesses and may increase the risk of lung cancer.

Smoking and Tobacco Use

Smoking cigarettes, beedis, cigars, hookah, and other tobacco products remains the single most important cause of lung cancer.

Tobacco smoke contains thousands of chemicals, many of which damage the DNA of lung cells. Continuous exposure over many years substantially increases the likelihood of developing lung cancer.

Although quitting smoking significantly reduces future risk, former smokers continue to benefit from regular medical evaluation if persistent respiratory symptoms develop.

Air Pollution

Lucknow frequently experiences periods of poor air quality due to vehicle emissions, construction activities, industrial pollution, and seasonal environmental conditions.

Long-term exposure to fine particulate matter (PM2.5) and other airborne pollutants may contribute to chronic lung inflammation and increase the risk of respiratory diseases, particularly among individuals with additional risk factors.

Occupational Exposure

People working in construction, manufacturing, transport, chemical industries, brick kilns, engineering, mining, and other industrial occupations may be exposed to harmful substances such as:

• Silica dust

• Asbestos

• Diesel exhaust

• Industrial chemicals

• Heavy metals

• Construction dust

Without appropriate protective measures, prolonged occupational exposure may increase the risk of developing lung cancer.

Biomass Fuel Smoke

In many parts of Uttar Pradesh, traditional cooking methods using wood, crop residue, coal, or other biomass fuels remain common.

Long-term exposure to indoor smoke in poorly ventilated kitchens has been associated with chronic respiratory diseases and may increase the risk of lung cancer, particularly among women.

Previous Lung Diseases

Individuals with chronic respiratory illnesses such as:

• Chronic Obstructive Pulmonary Disease (COPD)

• Pulmonary fibrosis

• Bronchiectasis

• Previous tuberculosis

should seek medical evaluation if respiratory symptoms persist or worsen.

Family History and Genetic Factors

Although most lung cancers are not inherited directly, a family history of lung cancer may increase an individual’s susceptibility.

Certain genetic mutations also influence tumour behaviour and help determine whether targeted therapy or immunotherapy may be appropriate.

Increasing Age

The risk of lung cancer generally increases with age because harmful environmental exposures accumulate over many years.

However, younger adults can also develop lung cancer, particularly when genetic or environmental factors are involved.

Understanding the Lungs

The lungs are responsible for supplying oxygen to every organ while removing carbon dioxide from the body.

The right lung contains three lobes, while the left lung contains two lobes to accommodate the heart. Air enters through the trachea, passes into the bronchi, and reaches millions of tiny air sacs called alveoli, where oxygen enters the bloodstream.

Because the lungs remain in continuous contact with the external environment, they are exposed every day to cigarette smoke, dust, pollution, allergens, industrial chemicals, and infectious organisms. Repeated exposure to these harmful substances may damage the DNA of normal lung cells. If this damage is not repaired successfully, abnormal cells can multiply uncontrollably and eventually form a tumour.

During the early stages, lung cancer may remain confined to the lungs. If left untreated, it can spread through the lymphatic system or bloodstream to nearby lymph nodes and distant organs such as the brain, liver, bones, or adrenal glands. Early diagnosis and timely treatment remain the most important factors for improving long-term outcomes.

Patients in Lucknow also benefit from access to advanced pulmonary and oncology services within the city, where increasing expertise in bronchoscopy, EBUS-guided procedures, multidisciplinary oncology care, and respiratory medicine supports earlier diagnosis and more personalised treatment planning.

What Is Lung Cancer?

Lung cancer is a disease in which abnormal cells within the lungs begin to grow uncontrollably, forming a tumour that interferes with the normal function of the lungs. Unlike healthy cells, which grow and divide in a regulated manner, cancer cells continue multiplying without control. Over time, these abnormal cells may invade nearby lung tissue, block the airways, spread to lymph nodes, and eventually reach distant organs such as the brain, liver, bones, or adrenal glands.

The lungs are constantly exposed to the external environment through every breath we take. Tobacco smoke, air pollution, industrial chemicals, dust particles, and harmful gases can damage the DNA of lung cells. When this damage is not repaired properly, normal cells may become cancerous and begin multiplying uncontrollably.

One of the biggest challenges with lung cancer is that it often develops silently. Many patients experience no symptoms during the early stages or mistake mild symptoms for common respiratory infections or allergies. As a result, diagnosis may be delayed until the disease has progressed.

Fortunately, advances in medical science have transformed lung cancer treatment. Today, doctors can use advanced imaging, molecular testing, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary cancer care to create highly personalised treatment plans.

Types of Lung Cancer

Lung cancer is classified according to the appearance of cancer cells under the microscope. Determining the exact type is essential because treatment and prognosis vary significantly.

The two major categories are:

• Non-Small Cell Lung Cancer (NSCLC)

• Small Cell Lung Cancer (SCLC)

Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer accounts for nearly 85% of all lung cancer cases.

Compared with Small Cell Lung Cancer, NSCLC generally grows more slowly and offers more treatment options when diagnosed at an early stage.

It is divided into three major subtypes.

Adenocarcinoma

Adenocarcinoma is the most common type of lung cancer worldwide and is increasingly diagnosed in people who have never smoked.

It usually develops in the outer portions of the lungs and may remain unnoticed during the early stages.

Common symptoms include:

• Persistent cough

• Breathlessness

• Mild chest discomfort

• Fatigue

• Poor appetite

• Unexplained weight loss

Because adenocarcinoma frequently contains genetic mutations, doctors usually recommend molecular testing for:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

These biomarkers help determine whether targeted therapy may be beneficial.

Squamous Cell Carcinoma

Squamous Cell Carcinoma develops within the larger airways of the lungs and has a strong association with long-term tobacco use.

Since these tumours often arise near the central bronchi, symptoms may develop earlier.

Patients commonly experience:

• Persistent cough

• Blood in sputum

• Wheezing

• Chest pain

• Recurrent chest infections

• Difficulty breathing

Treatment depends on the stage of disease and may include surgery, chemotherapy, radiation therapy, immunotherapy, or combinations of these treatments.

Large Cell Carcinoma

Large Cell Carcinoma is a relatively uncommon subtype of NSCLC.

It can arise in almost any part of the lung and may grow more rapidly than adenocarcinoma or squamous cell carcinoma.

Treatment recommendations depend on:

• Tumour size

• Stage of disease

• Molecular profile

• Age

• Lung function

• Overall health

Early diagnosis improves the chances of successful treatment.

Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer accounts for approximately 10–15% of all lung cancers.

Compared with NSCLC, SCLC usually grows rapidly and often spreads to other organs before symptoms become obvious.

Common sites of spread include:

• Brain

• Liver

• Bones

• Adrenal glands

• Lymph nodes

Although surgery is less commonly performed, chemotherapy, radiation therapy, and immunotherapy remain important treatment options.

Metastatic Lung Cancer

Metastatic lung cancer refers to lung cancer that has spread beyond the lungs to distant organs.

Cancer cells travel through the bloodstream or lymphatic system and establish new tumours in other parts of the body.

Common sites include:

• Brain

• Liver

• Bones

• Adrenal glands

• Distant lymph nodes

Although metastatic disease is more challenging to treat, advances in targeted therapy, immunotherapy, and supportive care have significantly improved quality of life and survival for many patients.

Early Symptoms of Lung Cancer

Symptoms vary depending on the type, size, and location of the tumour.

Some patients experience only mild symptoms during the early stages, while others remain symptom-free until the disease has progressed.

Anyone with persistent respiratory symptoms lasting more than two to three weeks should seek medical evaluation.

Persistent Cough

A cough that lasts several weeks or gradually worsens is one of the earliest warning signs of lung cancer.

Smokers often mistake a chronic cough as a normal consequence of smoking, which may delay diagnosis.

Coughing Up Blood

Even a small amount of blood in the sputum should never be ignored.

Although infections may occasionally cause blood-stained sputum, lung cancer must always be excluded.

Immediate medical evaluation is recommended.

Chest Pain

Persistent chest pain may occur when a tumour affects the lung lining or nearby structures.

Patients often report pain that:

• Worsens while coughing

• Increases during deep breathing

• Persists despite pain medication

• Interferes with daily activities

Shortness of Breath

Breathlessness may develop when a tumour blocks an airway, reduces lung capacity, or causes fluid to accumulate around the lungs.

Initially, symptoms may occur only during physical activity before gradually worsening.

Wheezing

New-onset wheezing without a previous history of asthma or allergies should be medically evaluated.

A tumour narrowing the airway may partially block airflow and produce wheezing.

Hoarseness of Voice

Lung tumours located near the nerves controlling the vocal cords may cause:

• Persistent hoarseness

• Voice changes

• Difficulty speaking loudly

Hoarseness lasting more than three weeks should be assessed by a doctor.

Recurrent Chest Infections

Repeated episodes of pneumonia or bronchitis affecting the same part of the lung may indicate an underlying airway obstruction caused by a tumour.

Prompt investigation is recommended.

Fatigue

Cancer-related fatigue is different from ordinary tiredness.

Patients commonly experience:

• Persistent exhaustion

• Reduced energy levels

• Difficulty performing daily activities

• Poor recovery despite adequate sleep

Unexplained Weight Loss

Unexpected weight loss without dieting or increased physical activity may indicate an underlying medical condition, including lung cancer.

It is often accompanied by:

• Poor appetite

• Muscle loss

• Weakness

• Reduced physical stamina

Bone Pain

If lung cancer spreads to the bones, patients may develop persistent pain involving:

• Spine

• Ribs

• Shoulder

• Pelvis

• Hip

Persistent bone pain should always be investigated.

Headaches and Neurological Symptoms

When lung cancer spreads to the brain, symptoms may include:

• Persistent headaches

• Dizziness

• Weakness

• Vision changes

• Difficulty walking

• Seizures

These symptoms require urgent medical attention.

Causes and Risk Factors

Lung cancer develops because of a combination of environmental, lifestyle, occupational, and genetic factors.

Major risk factors include:

• Cigarette smoking

• Beedi smoking

• Hookah smoking

• Second-hand smoke

• Air pollution

• Industrial emissions

• Construction dust

• Silica exposure

• Asbestos

• Diesel exhaust

• Biomass fuel smoke

• Previous tuberculosis

• COPD

• Pulmonary fibrosis

• Family history of lung cancer

• Increasing age

• Genetic mutations

For people living in Lucknow and across Uttar Pradesh, exposure to urban air pollution, construction dust, biomass fuel smoke in rural communities, industrial emissions, and occupational hazards may contribute to respiratory health risks alongside tobacco use.

Who Is at Higher Risk?

The following individuals should pay particular attention to persistent respiratory symptoms:

• Current smokers

• Former smokers

• Adults above 50 years of age

• People exposed to second-hand smoke

• Workers in construction, manufacturing, transport, brick kilns, engineering, mining, and chemical industries

• Individuals with COPD or previous tuberculosis

• People with a family history of lung cancer

• Residents exposed to prolonged air pollution or occupational dust

Being at higher risk does not necessarily mean a person will develop lung cancer. However, recognising these factors encourages earlier medical evaluation, timely diagnosis, and access to appropriate treatment when needed.

When Should You Consult a Lung Cancer Specialist?

Many people ignore persistent respiratory symptoms because they assume they are caused by seasonal infections, allergies, smoking, ageing, or pollution. Unfortunately, delaying medical evaluation may allow lung cancer to progress before it is diagnosed.

Early diagnosis remains one of the most important factors influencing successful treatment. Patients diagnosed during the early stages generally have more treatment options and better long-term outcomes than those diagnosed after the disease has spread.

If you live in Lucknow, Kanpur, Prayagraj, Varanasi, Gorakhpur, Bareilly, Ayodhya, Agra, Meerut, Aligarh, Moradabad, Jhansi, or nearby regions, you should consult a doctor if you experience:

• A cough lasting more than three weeks

• Coughing up blood

• Persistent chest pain

• Increasing shortness of breath

• Hoarseness of voice

• Wheezing without asthma

• Recurrent pneumonia or chest infections

• Unexplained weight loss

• Persistent fatigue

• Bone pain or headaches associated with respiratory symptoms

Seeking medical advice does not necessarily mean you have lung cancer. However, prompt evaluation helps identify the underlying cause and allows treatment to begin as early as possible if cancer is diagnosed.

How Is Lung Cancer Diagnosed?

Modern lung cancer diagnosis involves much more than identifying an abnormal shadow on a chest X-ray. Specialists use advanced imaging, tissue biopsy, pathology, molecular testing, and multidisciplinary assessment to accurately diagnose the disease and recommend the most appropriate treatment.

Patients from Lucknow can complete most investigations locally before seeking an expert review or second opinion.

Medical History and Physical Examination

Every consultation begins with a detailed discussion about your symptoms and medical history.

Your doctor may ask about:

• Duration and progression of symptoms

• Smoking or tobacco history

• Exposure to second-hand smoke

• Occupational exposure to dust or chemicals

• Previous tuberculosis or chronic lung disease

• Family history of cancer

• Weight loss or appetite changes

• Current medications

• Previous cancer treatment

• Other existing medical conditions

A physical examination may identify enlarged lymph nodes, abnormal breathing sounds, reduced oxygen levels, or other findings requiring further investigation.

Chest X-ray

A chest X-ray is often the first imaging investigation when lung cancer is suspected.

Although it cannot diagnose every lung tumour, it helps identify abnormalities such as:

• Lung masses

• Persistent pneumonia

• Lung collapse

• Fluid around the lungs

• Enlarged lymph nodes

If an abnormality is detected, additional imaging is generally recommended.

CT Scan (Computed Tomography)

A CT scan provides detailed cross-sectional images of the lungs and surrounding structures.

Compared with a standard chest X-ray, CT scanning provides much more information regarding:

• Exact tumour location

• Tumour size

• Airway involvement

• Blood vessel involvement

• Enlarged lymph nodes

• Spread within the chest

CT imaging also helps specialists determine whether surgery, biopsy, or additional investigations are required.

PET-CT Scan

PET-CT combines Positron Emission Tomography (PET) with Computed Tomography (CT).

Before the scan, a small amount of radioactive glucose is injected into the bloodstream. Cancer cells consume more glucose than normal tissues, making them appear as areas of increased metabolic activity.

PET-CT helps determine:

• Whether cancer has spread beyond the lungs

• Lymph node involvement

• Suitability for surgery

• Response to treatment

• Possible recurrence after treatment

PET-CT has become one of the most valuable investigations for accurately staging lung cancer.

MRI Scan

MRI is recommended when doctors suspect that lung cancer has spread to the brain, spine, or other soft tissues.

MRI provides detailed images of the nervous system and is particularly useful for patients experiencing:

• Persistent headaches

• Dizziness

• Weakness

• Vision problems

• Difficulty walking

• Seizures

Bronchoscopy

Bronchoscopy is a minimally invasive procedure that allows specialists to examine the inside of the airways using a flexible camera.

During bronchoscopy, doctors can:

• Examine the airways

• Identify abnormal growths

• Collect tissue samples

• Assess airway narrowing

• Remove secretions when necessary

The procedure is generally performed under sedation, and most patients return home the same day.

Endobronchial Ultrasound (EBUS)

Endobronchial Ultrasound combines bronchoscopy with ultrasound imaging.

This technique enables specialists to examine lymph nodes deep within the chest and obtain biopsy samples without major surgery.

EBUS plays a vital role in accurate staging and treatment planning.

CT-Guided Needle Biopsy

When a tumour is located near the outer portion of the lung, a CT-guided needle biopsy may be recommended.

Using CT imaging for guidance, a specialised needle is inserted through the chest wall to obtain a tissue sample.

The sample is then examined by a pathologist to confirm the diagnosis.

Histopathology

A biopsy remains the gold standard for confirming lung cancer.

The pathology report provides detailed information about:

• Type of lung cancer

• Tumour grade

• Cell characteristics

• Additional microscopic findings that influence treatment planning

Without biopsy confirmation, a definitive diagnosis generally cannot be established.

Molecular Testing

One of the greatest advances in modern lung cancer care is molecular profiling.

Instead of identifying cancer only by its microscopic appearance, specialists analyse specific genetic alterations within tumour cells.

Common biomarkers include:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

• PD-L1

Patients with these biomarkers may benefit from targeted therapy or immunotherapy.

Molecular testing has become an essential part of personalised treatment planning for many patients with Non-Small Cell Lung Cancer.

Liquid Biopsy

Liquid biopsy is an advanced blood test that detects tumour DNA circulating in the bloodstream.

It may be useful:

• When tissue biopsy is difficult

• To identify additional genetic mutations

• To monitor treatment response

• To evaluate suspected recurrence

Although not appropriate for every patient, liquid biopsy has become an increasingly valuable tool in precision oncology.

Understanding Lung Cancer Staging

Once lung cancer has been confirmed, specialists determine how far the disease has spread.

This process is called staging.

Accurate staging is essential because treatment recommendations vary significantly between early-stage and advanced disease.

Stage 0

Cancer cells remain confined to the lining of the airways without invading deeper tissues.

Treatment at this stage often provides excellent long-term outcomes.

Stage I

The tumour remains confined to the lung without lymph node involvement.

Many patients diagnosed at this stage are suitable candidates for surgery or other treatments with curative intent.

Stage II

The tumour may be larger or involve nearby lymph nodes.

Treatment often includes surgery followed by chemotherapy and, in selected cases, radiation therapy.

Stage III

Cancer has spread to lymph nodes within the chest or nearby structures.

Treatment usually combines:

• Chemotherapy

• Radiation therapy

• Immunotherapy

• Surgery in carefully selected patients

Management generally involves discussion by a multidisciplinary oncology team.

Stage IV

Stage IV lung cancer indicates that the disease has spread beyond the lungs to distant organs such as the brain, liver, bones, or adrenal glands.

Although Stage IV disease is generally not considered curable, advances in targeted therapy, immunotherapy, chemotherapy, and supportive care have significantly improved survival and quality of life for many patients.

Personalised Treatment Planning

No two lung cancer patients are exactly alike.

Every treatment recommendation is based on:

• Type of lung cancer

• Stage of disease

• Molecular profile

• Patient’s age

• Overall health

• Lung function

• Previous treatments

• Individual treatment goals

Patients from Lucknow and across Uttar Pradesh seeking a second opinion through Fuda Cancer Hospital can have their CT scans, PET-CT images, biopsy reports, pathology findings, and molecular testing reviewed by an experienced multidisciplinary oncology team. This collaborative approach helps ensure that every patient receives an evidence-based, personalised treatment plan tailored to their diagnosis and clinical condition before treatment begins.

When Should You Consult a Lung Cancer Specialist?

Many people ignore persistent respiratory symptoms because they assume they are caused by seasonal infections, allergies, smoking, ageing, or pollution. Unfortunately, delaying medical evaluation may allow lung cancer to progress before it is diagnosed.

Early diagnosis remains one of the most important factors influencing successful treatment. Patients diagnosed during the early stages generally have more treatment options and better long-term outcomes than those diagnosed after the disease has spread.

If you live in Lucknow, Kanpur, Prayagraj, Varanasi, Gorakhpur, Bareilly, Ayodhya, Agra, Meerut, Aligarh, Moradabad, Jhansi, or nearby regions, you should consult a doctor if you experience:

• A cough lasting more than three weeks

• Coughing up blood

• Persistent chest pain

• Increasing shortness of breath

• Hoarseness of voice

• Wheezing without asthma

• Recurrent pneumonia or chest infections

• Unexplained weight loss

• Persistent fatigue

• Bone pain or headaches associated with respiratory symptoms

Seeking medical advice does not necessarily mean you have lung cancer. However, prompt evaluation helps identify the underlying cause and allows treatment to begin as early as possible if cancer is diagnosed.

How Is Lung Cancer Diagnosed?

Modern lung cancer diagnosis involves much more than identifying an abnormal shadow on a chest X-ray. Specialists use advanced imaging, tissue biopsy, pathology, molecular testing, and multidisciplinary assessment to accurately diagnose the disease and recommend the most appropriate treatment.

Patients from Lucknow can complete most investigations locally before seeking an expert review or second opinion.

Medical History and Physical Examination

Every consultation begins with a detailed discussion about your symptoms and medical history.

Your doctor may ask about:

• Duration and progression of symptoms

• Smoking or tobacco history

• Exposure to second-hand smoke

• Occupational exposure to dust or chemicals

• Previous tuberculosis or chronic lung disease

• Family history of cancer

• Weight loss or appetite changes

• Current medications

• Previous cancer treatment

• Other existing medical conditions

A physical examination may identify enlarged lymph nodes, abnormal breathing sounds, reduced oxygen levels, or other findings requiring further investigation.

Chest X-ray

A chest X-ray is often the first imaging investigation when lung cancer is suspected.

Although it cannot diagnose every lung tumour, it helps identify abnormalities such as:

• Lung masses

• Persistent pneumonia

• Lung collapse

• Fluid around the lungs

• Enlarged lymph nodes

If an abnormality is detected, additional imaging is generally recommended.

CT Scan (Computed Tomography)

A CT scan provides detailed cross-sectional images of the lungs and surrounding structures.

Compared with a standard chest X-ray, CT scanning provides much more information regarding:

• Exact tumour location

• Tumour size

• Airway involvement

• Blood vessel involvement

• Enlarged lymph nodes

• Spread within the chest

CT imaging also helps specialists determine whether surgery, biopsy, or additional investigations are required.

PET-CT Scan

PET-CT combines Positron Emission Tomography (PET) with Computed Tomography (CT).

Before the scan, a small amount of radioactive glucose is injected into the bloodstream. Cancer cells consume more glucose than normal tissues, making them appear as areas of increased metabolic activity.

PET-CT helps determine:

• Whether cancer has spread beyond the lungs

• Lymph node involvement

• Suitability for surgery

• Response to treatment

• Possible recurrence after treatment

PET-CT has become one of the most valuable investigations for accurately staging lung cancer.

MRI Scan

MRI is recommended when doctors suspect that lung cancer has spread to the brain, spine, or other soft tissues.

MRI provides detailed images of the nervous system and is particularly useful for patients experiencing:

• Persistent headaches

• Dizziness

• Weakness

• Vision problems

• Difficulty walking

• Seizures

Bronchoscopy

Bronchoscopy is a minimally invasive procedure that allows specialists to examine the inside of the airways using a flexible camera.

During bronchoscopy, doctors can:

• Examine the airways

• Identify abnormal growths

• Collect tissue samples

• Assess airway narrowing

• Remove secretions when necessary

The procedure is generally performed under sedation, and most patients return home the same day.

Endobronchial Ultrasound (EBUS)

Endobronchial Ultrasound combines bronchoscopy with ultrasound imaging.

This technique enables specialists to examine lymph nodes deep within the chest and obtain biopsy samples without major surgery.

EBUS plays a vital role in accurate staging and treatment planning.

CT-Guided Needle Biopsy

When a tumour is located near the outer portion of the lung, a CT-guided needle biopsy may be recommended.

Using CT imaging for guidance, a specialised needle is inserted through the chest wall to obtain a tissue sample.

The sample is then examined by a pathologist to confirm the diagnosis.

Histopathology

A biopsy remains the gold standard for confirming lung cancer.

The pathology report provides detailed information about:

• Type of lung cancer

• Tumour grade

• Cell characteristics

• Additional microscopic findings that influence treatment planning

Without biopsy confirmation, a definitive diagnosis generally cannot be established.

Molecular Testing

One of the greatest advances in modern lung cancer care is molecular profiling.

Instead of identifying cancer only by its microscopic appearance, specialists analyse specific genetic alterations within tumour cells.

Common biomarkers include:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

• PD-L1

Patients with these biomarkers may benefit from targeted therapy or immunotherapy.

Molecular testing has become an essential part of personalised treatment planning for many patients with Non-Small Cell Lung Cancer.

Liquid Biopsy

Liquid biopsy is an advanced blood test that detects tumour DNA circulating in the bloodstream.

It may be useful:

• When tissue biopsy is difficult

• To identify additional genetic mutations

• To monitor treatment response

• To evaluate suspected recurrence

Although not appropriate for every patient, liquid biopsy has become an increasingly valuable tool in precision oncology.

Understanding Lung Cancer Staging

Once lung cancer has been confirmed, specialists determine how far the disease has spread.

This process is called staging.

Accurate staging is essential because treatment recommendations vary significantly between early-stage and advanced disease.

Stage 0

Cancer cells remain confined to the lining of the airways without invading deeper tissues.

Treatment at this stage often provides excellent long-term outcomes.

Stage I

The tumour remains confined to the lung without lymph node involvement.

Many patients diagnosed at this stage are suitable candidates for surgery or other treatments with curative intent.

Stage II

The tumour may be larger or involve nearby lymph nodes.

Treatment often includes surgery followed by chemotherapy and, in selected cases, radiation therapy.

Stage III

Cancer has spread to lymph nodes within the chest or nearby structures.

Treatment usually combines:

• Chemotherapy

• Radiation therapy

• Immunotherapy

• Surgery in carefully selected patients

Management generally involves discussion by a multidisciplinary oncology team.

Stage IV

Stage IV lung cancer indicates that the disease has spread beyond the lungs to distant organs such as the brain, liver, bones, or adrenal glands.

Although Stage IV disease is generally not considered curable, advances in targeted therapy, immunotherapy, chemotherapy, and supportive care have significantly improved survival and quality of life for many patients.

Personalised Treatment Planning

No two lung cancer patients are exactly alike.

Every treatment recommendation is based on:

• Type of lung cancer

• Stage of disease

• Molecular profile

• Patient’s age

• Overall health

• Lung function

• Previous treatments

• Individual treatment goals

Patients from Lucknow and across Uttar Pradesh seeking a second opinion through Fuda Cancer Hospital can have their CT scans, PET-CT images, biopsy reports, pathology findings, and molecular testing reviewed by an experienced multidisciplinary oncology team. This collaborative approach helps ensure that every patient receives an evidence-based, personalised treatment plan tailored to their diagnosis and clinical condition before treatment begins.

Advanced Treatment Options for Lung Cancer

Modern lung cancer treatment has evolved significantly over the past two decades. Today, treatment is no longer based only on the size or location of the tumour. Specialists carefully evaluate the type of lung cancer, stage of disease, molecular profile, lung function, age, overall health, and the patient’s treatment goals before recommending a personalised treatment plan.

For patients from Lucknow, Kanpur, Prayagraj, Varanasi, Gorakhpur, Bareilly, Ayodhya, Agra, Meerut, Aligarh, Moradabad, Jhansi, and across Uttar Pradesh, several treatment options are available. Depending on the diagnosis, one treatment or a combination of therapies may be recommended.

Surgery for Lung Cancer

Surgery remains one of the most effective treatment options for patients diagnosed with early-stage Non-Small Cell Lung Cancer (NSCLC). The primary goal is to remove the tumour completely while preserving as much healthy lung tissue as possible.

Before recommending surgery, doctors carefully assess:

• Stage of disease

• Tumour size and location

• Lung function

• Heart health

• Overall physical fitness

• Existing medical conditions

Types of Lung Cancer Surgery

Wedge Resection

A wedge resection removes the tumour together with a small margin of surrounding healthy lung tissue. This procedure may be suitable for very small tumours or for patients with reduced lung function.

Segmentectomy

A segmentectomy removes one anatomical segment of the lung while preserving the remaining healthy tissue. It is appropriate for carefully selected patients with early-stage disease.

Lobectomy

Lobectomy involves removal of one complete lobe of the lung and remains the standard surgical treatment for many early-stage lung cancers.

Pneumonectomy

When the tumour involves a large portion of the lung or major airways, removal of the entire lung may occasionally be necessary. Although this is a major operation, many patients recover well with pulmonary rehabilitation and structured follow-up.

Chemotherapy

Chemotherapy uses specialised medicines to destroy rapidly growing cancer cells throughout the body.

Chemotherapy may be recommended:

• Before surgery (Neoadjuvant Chemotherapy)

• After surgery (Adjuvant Chemotherapy)

• Along with radiation therapy

• For advanced or metastatic lung cancer

• To reduce symptoms and improve quality of life

Treatment is generally administered in cycles, allowing adequate recovery between sessions.

Possible Side Effects

Modern supportive medications have significantly improved the management of chemotherapy-related side effects.

Some patients may experience:

• Fatigue

• Nausea and vomiting

• Temporary hair loss

• Reduced immunity

• Mouth ulcers

• Loss of appetite

• Tingling or numbness in the hands and feet

Many of these side effects are temporary and can be managed with appropriate medical care.

Radiation Therapy

Radiation therapy uses precisely targeted high-energy radiation beams to destroy cancer cells while minimising damage to surrounding healthy tissues.

Radiation therapy may be recommended:

• When surgery is not suitable

• Before surgery to shrink the tumour

• After surgery to reduce recurrence risk

• Combined with chemotherapy

• To relieve symptoms in advanced disease

Modern Radiation Techniques

Intensity-Modulated Radiation Therapy (IMRT)

IMRT delivers radiation from multiple angles while adjusting beam intensity to maximise tumour control and reduce exposure to nearby healthy organs.

Stereotactic Body Radiation Therapy (SBRT)

SBRT delivers highly focused, high-dose radiation over a limited number of treatment sessions. It may be appropriate for selected patients with small, localised tumours who are not candidates for surgery.

Targeted Therapy

Targeted therapy has transformed the treatment of many patients with Non-Small Cell Lung Cancer.

Unlike chemotherapy, targeted therapy specifically attacks cancer cells carrying certain genetic mutations while reducing damage to many normal cells.

Before treatment begins, molecular testing helps identify biomarkers such as:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

Patients with these mutations may benefit from medicines specifically designed to target these genetic alterations.

Advantages of Targeted Therapy

• Personalised treatment approach

• Often available as oral medication

• Different side-effect profile compared with chemotherapy

• Effective disease control in selected patients

Immunotherapy

Immunotherapy is one of the most important advances in modern cancer care.

Instead of directly attacking cancer cells, immunotherapy helps the body’s immune system recognise and destroy them more effectively.

Doctors often perform PD-L1 testing or other biomarker assessments before recommending immunotherapy.

Immunotherapy may be used:

• Alone

• Combined with chemotherapy

• Following chemotherapy and radiation therapy

• For advanced lung cancer

• In selected patients after surgery

Cryotherapy (Cryosurgery)

Cryotherapy, also known as Cryoablation, is a minimally invasive procedure that destroys selected tumours using extremely low temperatures.

Using advanced imaging guidance, a specialised probe is placed within or near the tumour. Controlled freezing and thawing cycles destroy cancer cells while preserving much of the surrounding healthy tissue.

Potential benefits include:

• Minimally invasive treatment

• Reduced blood loss

• Smaller incisions

• Faster recovery

• Preservation of healthy lung tissue in selected patients

Suitability depends on tumour size, location, and the patient’s overall clinical condition.

NanoKnife Irreversible Electroporation (IRE)

NanoKnife IRE is an advanced treatment that uses carefully controlled electrical pulses rather than heat or freezing to destroy selected tumours.

The electrical pulses create microscopic openings in cancer cell membranes, leading to cell death while helping preserve nearby blood vessels, nerves, and other important structures.

NanoKnife IRE may be considered for selected patients whose tumours are located close to vital anatomical structures.

Recovery and Rehabilitation

Recovery after lung cancer treatment depends on the treatment received and the patient’s overall health.

Recovery programmes may include:

• Pulmonary rehabilitation

• Breathing exercises

• Gradual increase in physical activity

• Smoking cessation support

• Nutritional counselling

• Regular follow-up imaging

• Symptom monitoring

• Emotional support

A structured rehabilitation programme often helps patients improve lung function, reduce fatigue, and regain independence.

Nutrition During Lung Cancer Treatment

Good nutrition supports healing, preserves muscle strength, and improves tolerance to treatment.

General dietary recommendations include:

• Eat small, frequent meals.

• Include protein-rich foods such as eggs, fish, pulses, paneer, tofu, lean meat, and dairy products.

• Eat a variety of fresh fruits and vegetables.

• Stay well hydrated.

• Limit processed foods and excessive sugar intake.

• Consult a dietitian if appetite decreases or swallowing becomes difficult.

Why Lucknow Patients Choose Fuda Cancer Hospital

Patients from Lucknow and across Uttar Pradesh often seek expert guidance to better understand their diagnosis and explore advanced treatment options.

Through its collaboration with Rekosh Health Care, Fuda Cancer Hospital offers:

• Expert second opinions

• Multidisciplinary case reviews

• Personalised treatment planning

• Review of CT scans, PET-CT scans, biopsy reports, and pathology findings

• Guidance on advanced treatment options

• Consultation support through Mumbai and Noida centres

• Long-term follow-up coordination

Treatment Journey for Patients from Lucknow

Step 1 – Book an Expert Consultation

Patients can begin with an online or in-person consultation to discuss their diagnosis, symptoms, and previous treatments.

Step 2 – Submit Medical Reports

The oncology team reviews:

• CT scans

• PET-CT scans

• MRI reports

• Bronchoscopy findings

• Biopsy reports

• Histopathology reports

• Molecular testing reports

• Previous treatment records

Step 3 – Multidisciplinary Case Review

Specialists evaluate the type of cancer, stage, molecular profile, lung function, and overall health before preparing a personalised treatment recommendation.

Step 4 – Individualised Treatment Planning

Depending on the diagnosis, treatment may include:

• Surgery

• Chemotherapy

• Radiation Therapy

• Targeted Therapy

• Immunotherapy

• Cryotherapy

• NanoKnife IRE

• Supportive and palliative care

Step 5 – Long-Term Follow-up

Patients continue with scheduled reviews, imaging, pulmonary rehabilitation, nutritional counselling, and supportive care to monitor recovery and detect recurrence early.

Lung Cancer Treatment Cost in Lucknow

Treatment costs vary depending on the stage of disease, investigations required, medications, hospital stay, and treatment approach.

Actual treatment costs depend on the patient’s diagnosis, treatment plan, medications, and duration of care.

Prevention Tips

Although not every case of lung cancer can be prevented, the following measures may reduce the overall risk:

• Stop smoking and avoid all tobacco products.

• Avoid second-hand smoke.

• Reduce exposure to air pollution and occupational dust.

• Use appropriate protective equipment in workplaces with silica or chemical exposure.

• Maintain a healthy diet and exercise regularly.

• Seek medical evaluation for persistent respiratory symptoms.

• Attend regular health check-ups if you have significant risk factors.

Frequently Asked Questions

1. Can non-smokers develop lung cancer?

Yes. Lung cancer can occur in non-smokers due to genetic factors, air pollution, passive smoking, occupational exposure, or previous lung diseases.

2. What are the earliest symptoms of lung cancer?

Persistent cough, breathlessness, chest pain, coughing up blood, fatigue, hoarseness, repeated chest infections, and unexplained weight loss.

3. Is lung cancer curable?

Some early-stage lung cancers can be treated with curative intent. The outcome depends on the cancer type, stage, and response to treatment.

4. Is surgery necessary for every patient?

No. Treatment depends on the type and stage of lung cancer. Many patients receive chemotherapy, radiation therapy, targeted therapy, immunotherapy, or combinations of these treatments.

5. What is molecular testing?

Molecular testing identifies genetic mutations such as EGFR, ALK, ROS1, and others that help doctors determine whether targeted therapy is appropriate.

6. What is immunotherapy?

Immunotherapy helps the body’s immune system recognise and attack cancer cells and may be recommended for eligible patients.

7. What is Cryotherapy?

Cryotherapy is a minimally invasive procedure that destroys selected tumours using extremely low temperatures.

8. What is NanoKnife IRE?

NanoKnife IRE uses electrical pulses to destroy selected tumours while helping preserve nearby blood vessels and nerves.

9. Can I seek a second opinion before starting treatment?

Yes. Many patients choose to seek a second opinion to better understand their diagnosis and explore all available treatment options before beginning therapy.

10. Can treatment planning begin after an online consultation?

Yes. Many patients begin by sharing their medical reports online, allowing specialists to review the case and recommend appropriate investigations or treatment before an in-person visit if required.

Conclusion

Advances in lung cancer diagnosis and treatment have created more opportunities for personalised care than ever before. Early diagnosis, accurate staging, molecular testing, and multidisciplinary treatment planning enable doctors to select therapies that are best suited to each patient’s condition.

For patients in Lucknow and across Uttar Pradesh, timely consultation and expert guidance can make a significant difference. Whether you have recently been diagnosed, are seeking a second opinion, or wish to explore advanced treatment options, discussing your case with an experienced oncology team can help you make informed decisions with confidence.

Schedule Your Consultation

If you or a loved one has been diagnosed with lung cancer, you can begin by requesting an expert consultation through Rekosh Health Care, the India partner supporting patient coordination with Fuda Cancer Hospital.

The team can assist with:

• Expert second opinions

• Medical report review

• Personalised treatment planning

• Guidance on advanced treatment options

• Coordination of consultations and follow-up care

Early consultation and timely medical evaluation can help you better understand your diagnosis and explore the most appropriate treatment options for your individual needs.